tiprankstipranks
Cidara Therapeutics (CDTX)
NASDAQ:CDTX
US Market

Cidara Therapeutics (CDTX) Income Statement

Compare
728 Followers

Cidara Therapeutics Income Statement

Last quarter (Q3 2024), Cidara Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Cidara Therapeutics's net income was $-15.54M. See Cidara Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 63.91M$ 64.29M$ 49.57M$ 12.07M$ 20.91M
Gross Profit
$ 62.38M$ 64.14M$ 49.38M$ -55.95M$ -25.49M
Operating Expenses
$ 86.86M$ 94.01M$ 91.83M$ 83.92M$ 62.64M
Depreciation and Amortization
$ 118.00K$ 143.00K$ 189.00K$ 286.00K$ 328.00K
EBITDA
$ -24.36M$ -33.36M$ -42.26M$ -71.56M$ -41.40M
Operating Income
$ -24.48M$ -29.72M$ -42.26M$ -71.85M$ -41.72M
Other Income/Expenses
$ 2.00M$ 191.00K$ -212.00K$ -262.00K$ 632.00K
Pretax Income
$ -22.49M$ -29.53M$ -42.47M$ -72.11M$ -41.09M
Net Income
$ -22.93M$ -29.80M$ -43.91M$ -72.37M$ -40.09M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -5.25$ -8.53$ -16.75$ -34.83$ -26.78
Diluted EPS
$ -5.25$ -8.53$ -16.74$ -34.83$ -26.78
Weighted Average Shares Outstanding
4.37M 3.49M 2.62M 2.08M 1.50M
Weighted Average Shares Outstanding (Diluted)
4.37M 3.49M 2.62M 2.08M 1.50M
Currency in USD

Cidara Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis